» Articles » PMID: 32116493

Complement System in Brain Architecture and Neurodevelopmental Disorders

Overview
Journal Front Neurosci
Date 2020 Mar 3
PMID 32116493
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Current evidence indicates that certain immune molecules such as components of the complement system are directly involved in neurobiological processes related to brain development, including neurogenesis, neuronal migration, synaptic remodeling, and response to prenatal or early postnatal brain insults. Consequently, complement system dysfunction has been increasingly implicated in disorders of neurodevelopmental origin, such as schizophrenia, autism spectrum disorder (ASD) and Rett syndrome. However, the mechanistic evidence for a causal relationship between impaired complement regulation and these disorders varies depending on the disease involved. Also, it is still unclear to what extent altered complement expression plays a role in these disorders through inflammation-independent or -dependent mechanisms. Furthermore, pathogenic mutations in specific complement components have been implicated in the etiology of 3MC syndrome, a rare autosomal recessive developmental disorder. The aims of this review are to discuss the current knowledge on the roles of the complement system in sculpting brain architecture and function during normal development as well as after specific inflammatory insults, such as maternal immune activation (MIA) during pregnancy, and to evaluate the existing evidence associating aberrant complement with developmental brain disorders.

Citing Articles

Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment.

Cao Y, Liang J, Dai B, Shan F, Xia Q BMC Psychiatry. 2024; 24(1):961.

PMID: 39741241 PMC: 11687148. DOI: 10.1186/s12888-024-06437-0.


Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms.

Magnusen A, Pandey M Int J Mol Sci. 2024; 25(22).

PMID: 39596318 PMC: 11594573. DOI: 10.3390/ijms252212252.


Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy.

Panicucci C, Sahin E, Bartolucci M, Casalini S, Brolatti N, Pedemonte M Cell Mol Life Sci. 2024; 81(1):393.

PMID: 39254732 PMC: 11387582. DOI: 10.1007/s00018-024-05426-6.


Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment.

Rosberg R, Smolag K, Sjolund J, Johansson E, Bergelin C, Wahlden J JCI Insight. 2024; 9(19).

PMID: 39172519 PMC: 11466187. DOI: 10.1172/jci.insight.179854.


Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.

Tschongov T, Konwar S, Busch A, Sievert C, Hartmann A, Noris M Front Immunol. 2024; 15:1383123.

PMID: 38799460 PMC: 11117068. DOI: 10.3389/fimmu.2024.1383123.


References
1.
Han M, Zhang J, Hashimoto K . Increased Levels of C1q in the Prefrontal Cortex of Adult Offspring after Maternal Immune Activation: Prevention by 7,8-Dihydroxyflavone. Clin Psychopharmacol Neurosci. 2017; 15(1):64-67. PMC: 5290721. DOI: 10.9758/cpn.2017.15.1.64. View

2.
Schafer D, Lehrman E, Kautzman A, Koyama R, Mardinly A, Yamasaki R . Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012; 74(4):691-705. PMC: 3528177. DOI: 10.1016/j.neuron.2012.03.026. View

3.
Koiliari E, Roussos P, Pasparakis E, Lencz T, Malhotra A, Siever L . The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males. Schizophr Res. 2014; 154(1-3):42-7. DOI: 10.1016/j.schres.2014.02.017. View

4.
Gorelik A, Sapir T, Ben-Reuven L, Reiner O . Complement C3 Affects Rac1 Activity in the Developing Brain. Front Mol Neurosci. 2018; 11:150. PMC: 5949353. DOI: 10.3389/fnmol.2018.00150. View

5.
Akbarian S, Kim J, Potkin S, Hetrick W, Bunney Jr W, Jones E . Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 1996; 53(5):425-36. DOI: 10.1001/archpsyc.1996.01830050061010. View